Italian recommendations for diagnosis and management of congenital myasthenic syndromes

Amelia Evoli, Adele D'Amico, Enrico Silvio Bertini, Lorenzo Maggi, Pia Bernasconi, Adele D’Amico, Raffaella Brugnoni, Chiara Fiorillo, Matteo Garibaldi, Guja Astrea, Claudio Bruno, Filippo Maria Santorelli, Rocco Liguori, Giovanni Antonini, Enrico Bertini, Carmelo Rodolico, Renato Mantegazza

Risultato della ricerca: Contributo in rivistaArticolo in rivista

14 Citazioni (Scopus)


Abstract Congenital myasthenic syndromes (CMS) are genetic disorders due to mutations in genes encoding proteins involved in the neuromuscular junction structure and function. CMS usually present in young children, but perinatal and adult onset has been reported. Clinical presentation is highly heterogeneous, ranging from mild symptoms to severe manifestations, sometimes with life-threatening respiratory episodes, especially in the first decade of life. Although considered rare, CMS are probably underestimated due to diagnostic difficulties. Because of the several therapeutic opportunities, CMS should be always considered in the differential diagnosis of neuromuscular disorders. The Italian Network on CMS proposes here recommendations for proper CMS diagnosis and management, aiming to guide clinicians in their practical approach to CMS patients.
Lingua originaleEnglish
pagine (da-a)457-468-468
RivistaNeurological Sciences
Stato di pubblicazionePubblicato - 2019


  • Congenital myasthenic syndromes
  • Disease Management
  • Health Planning Guidelines
  • Humans
  • Italy
  • Myasthenia gravis
  • Myasthenic Syndromes, Congenital
  • Myopathy
  • Neuromuscular junction
  • Recommendations


Entra nei temi di ricerca di 'Italian recommendations for diagnosis and management of congenital myasthenic syndromes'. Insieme formano una fingerprint unica.

Cita questo